Using RNAi-technology, Sep15 mRNA expression was reduced significantly between 85% and 95% in both HCT116 (P < 0.05) and HT29 (P < 0.001) colon cancer cells compared to plasmid-transfected controls (Figure 1a), respectively. The gene discussed is SELENOF; the disease is malignant colon neoplasm.